Performance and digestibilities of beef cattle fed diets supplemented with either soybean meal or roasted soybeans and implanted with Synovex

Impact of growth implants and low-level tannin supplementation on enteric emissions and nitrogen excretion in grazing steers

The primary objective of this experiment was to evaluate the effects of a growth-hormone implant (Revalor-G, Merck Animal Health., Rahway, NJ, USA) and tannin supplementation (Silvafeed BX, Silva Team, San Michele Mondovi CN, Italy) on enteric methane (CH4) emissions and estimated nitrogen (N) excretion in grazing steers. Steers (n = 20; initial body weight [IBW] = 343 ± 14 kg) were acclimated to use a portable automated head-chamber system (AHCS) to measure CH4 and a SmartFeed Pro automated feeder for dietary supplementation (C-Lock Inc., Rapid City, SD, USA). After the training period, steers were randomly assigned to a 2 × 2 factorial arrangements of treatments, with 2 levels of growth-hormone implants, no-implant (NO-IMP) or implanted (IMP), and 2 levels of tannin supplementation, no tannin supplementation (NO-TAN) or tannin supplementation (TAN). This created 4 treatment groups: (1) NO-TAN and NO-IMP, (2) TAN and NO-IMP, (3) IMP and NO-TAN, and (4) TAN and IMP. Tannin was offered daily at 0.30% dry matter intake (DMI) through 0.5 kg/hd/d sweetfeed supplement (Sweetfeed Mix, AgFinity., Eaton, CO, USA) with a targeted tannin intake at 48 g/hd/d. No (P ≥ 0.05) implant × tannin interaction was detected for any dependent variable, so only the main effects of implant (NO-IMP vs. IMP) and tannin supplementation (NO-TAN vs. TAN) are discussed. Implant status did not affect (P ≥ 0.56) final body weight (FBW) or average daily gain (ADG) during the 90 d grazing period. There was no effect (P ≥ 0.15) of growth implant on CH4 production or emission intensity (EI; g CH4/kg gain). Additionally, IMP steers tended (P ≤ 0.08) to have less CH4 yield (MY; g CH4/g DMI) and higher blood urea nitrogen (BUN) than NO-IMP steers. Tannin supplementation did not impact (P ≥ 0.26) FBW or ADG. However, NO-TAN steers tended (P = 0.06) to have a greater total DMI than steers supplemented with tannin. No effect (P ≥ 0.22) of tannin supplementation was observed for CH4 production and EI. Nitrogen utilization as measured through BUN, urine N, fecal N, or fecal P was similar (P ≥ 0.12) between TAN and NO-TAN animals. The findings indicate that low-level dietary supplementation to reduce enteric emissions is difficult in grazing systems due to inconsistent animal intake and that growth implants could be used as a strategy to improve growth performance and reduce EI of steers grazing improved pasture.

Protein metabolism, body composition and oxygen consumption in young bulls divergent in residual feed intake offered two contrasting forage-based diets

Protein metabolism and body composition have been identified as major determinants of residual feed intake (RFI) in beef cattle fed high-starch fattening diets. This study aimed to evaluate if these two identified RFI determinants in beef cattle are the same across two contrasting silage-based diets. During two consecutive years, an 84-day feed efficiency test (Test A) immediately followed by a second 112-day feed efficiency test (Test B) was carried out using a total of 100 animals offered either one of two diets (either corn silage- or grass silage-based) over 196 days. At the end of Test A, the 32 animals most divergent for RFI (16 extreme RFI animals per diet, eight low RFI and eight high RFI) were identified and evaluated during Test B for their i) N use efficiency (NUE; N retention/N intake) calculated either from a 10-d nitrogen balance trial or from estimations based on body composition changes occurring during the whole experiment (Test A and Test B; 196 days), ii) carcass and whole-body protein turnover rates analysed through the 3-methyl-histidine urinary excretion and the N isotopic turnover rates of urine, respectively, and iii) body composition measured at the slaughterhouse at the end of Test B. Oxygen consumption was measured during Test B for the 100 animals by two GreenFeed systems. Irrespective of the diet, efficient RFI animals tended (P = 0.08) to improve their NUE when N retention was estimated for 196 days or when considering their lower urinary urea-N to total N ratio (P = 0.03). In contrast, NUE calculated during the 10-d N balance showed no differences (P = 0.65) across RFI groups suggesting that this method may not be suitable to capture small NUE differences. Efficient RFI individuals presented higher dressing percentage and muscle deposition in the carcass (P = 0.003) but lighter rumen (P = 0.001), and a trend for lower oxygen consumption (P = 0.08) than inefficient RFI animals irrespective of the diet. Lower protein degradation rates of skeletal muscle and lower protein synthesis rates of plasma proteins were found in efficient RFI cattle but only with the corn silage-based diet (RFI × Diet; P = 0.02). The higher insulinaemia associated with the corn silage-based diet (P = 0.001) seemed to be a key metabolic feature explaining the positive association between protein turnover and RFI only in this diet. Feed N was more efficiently used for growth by efficient RFI animals regardless of the diet but lower protein turnover rates in efficient RFI animals were only observed with corn silage-based diets.

Hormone contents in peripheral tissues after correct and off-label use of growth promoting hormones in cattle: effect of the implant preparations Filaplix-H, Raglo, Synovex-H and Synovex Plus

Certain hormonal growth promoters are licensed in several beef producing countries outside the European Union (EU). Use in compliance with Good Veterinary Practice is mandatory. As risk assessment of hormone residues in animal tissues up to now has neglected potential off-label use, the present study dealt with two topics: 1) multiple treatment with the implant preparations Finaplix-H (200 mg trenbolone acetate), Ralgro (36 mg zeranol) and Synovex-H (200 mg testosterone propionate plus 20 mg estradiol benzoate) in heifers (1-fold, 3-fold and 10-fold dose), and 2) non-approved treatment of female veal calves (1-fold dose of Synovex-H or Synovex Plus with 200 mg trenbolone acetate plus 28 mg estradiol benzoate). Residues of estradiol-17beta, estradiol-17alpha, estrone and testosterone, trenbolone-17beta, trenbolone-17alpha and trendione or zeranol, respectively, were measured in loin, liver, kidney and peri-renal fat by high performance liquid chromatography/enzyme immunoassay (HPLC/EIA) after liquid-liquid extraction and solid-phase clean-up. The hormone residues in the multiple-dose experiments were dose-dependent and partially exceeded the threshold values: in the liver in one animal after 3-fold dose and in two animals after 10-fold dose of Finaplix-H, and in the liver and kidney after 3-fold and 10-fold dose of Synovex-H. Mean hormone residues in calves were mainly below those of heifers and did not infringe threshold values.